tranxene t-tab- clorazepate dipotassium tablet
recordati rare diseases, inc. - clorazepate dipotassium (unii: 63fn7g03xy) (clorazepic acid - unii:d51wo0g0l4) - clorazepate dipotassium 7.5 mg - tranxene is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. tranxene tablets are indicated as adjunctive therapy in the management of partial seizures. the effectiveness of tranxene tablets in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. long-term studies in epileptic patients, however, have shown continued therapeutic activity. the physician should reassess periodically the usefulness of the drug for the individual patient. tranxene tablets are indicated for the symptomatic relief of acute alcohol withdrawal. tranxene tablets are contraindicated in patients with a known hypersensitivity to the drug and in those with acute narrow angle glaucoma.
uni-tranxene 15 mg harde caps.
neuraxpharm belgium bv-srl - dikaliumchlorazepaat 15 mg - capsule, hard - 15 mg - dikaliumchlorazepaat 15 mg - potassium clorazepate
uni-tranxene 15 mg gél.
neuraxpharm belgium bv-srl - clorazépate dipotassique 15 mg - gélule - 15 mg - clorazépate dipotassique 15 mg - potassium clorazepate
tranxene 5 mg cápsula
neuraxpharm portugal, unipessoal lda - clorazepato dipotássico - cápsula - 5 mg - clorazepato dipotássico 5 mg - potassium clorazepate - n/a - duração do tratamento: curta ou média duração
tranxene 10 mg cápsula
neuraxpharm portugal, unipessoal lda - clorazepato dipotássico - cápsula - 10 mg - clorazepato dipotássico 10 mg - potassium clorazepate - n/a - duração do tratamento: curta ou média duração
tranxene 10 mg cápsula
neuraxpharm portugal, unipessoal lda - clorazepato dipotássico - cápsula - 10 mg - clorazepato dipotássico 10 mg - potassium clorazepate - n/a - duração do tratamento: curta ou média duração
tranxene 15 mg cápsula
neuraxpharm portugal, unipessoal lda - clorazepato dipotássico - cápsula - 15 mg - clorazepato dipotássico 15 mg - potassium clorazepate - n/a - duração do tratamento: curta ou média duração
tranxene 5 mg cápsula
neuraxpharm portugal, unipessoal lda - clorazepato dipotássico - cápsula - 5 mg - clorazepato dipotássico 5 mg - potassium clorazepate - n/a - duração do tratamento: curta ou média duração
tranxene 10 mg gél.
neuraxpharm belgium bv-srl - clorazépate dipotassique 10 mg - gélule - 10 mg - clorazépate dipotassique 10 mg - potassium clorazepate
tranxene 5 mg gél.
neuraxpharm belgium bv-srl - clorazépate dipotassique 5 mg - gélule - 5 mg - clorazépate dipotassique 5 mg - potassium clorazepate